Hbk Sorce Advisory LLC Agios Pharmaceuticals, Inc. Transaction History

Hbk Sorce Advisory LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$21.74 - $30.93 $1.35 Million - $1.92 Million	-62,000 Reduced 84.01%	11,798 $407,000
Q4 2022 Feb 09, 2023	BUY	$24.81 - $31.52 $444,074 - $564,176	17,899 Added 32.02%	73,798 $331,000
Q3 2022 Nov 14, 2022	BUY	$19.51 - $34.14 $1.09 Million - $1.91 Million	55,899 New	55,899 $169,000
Q4 2021 Feb 15, 2022	SELL	$29.58 - $49.78 $174,492 - $293,652	-5,899 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$33.87 - $55.93 $199,799 - $329,931	5,899 New	5,899 $206,000

232

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $3.05B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Hbk Sorce Advisory LLC, based on Form 13F filings with the SEC.

Stay updated on Hbk Sorce Advisory LLC with notifications on news.